Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-30 · accession 0000950170-25-012639 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-02-03 | 2025-01-30 | DLB | Rollins Emily | Dir | S - Sale | $84.90 | -1,000 | 6,493 | -13% | -$84.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-30 | S | D | 1,000 | $84.90 | 6,493 | D | — | — | (F1) Shares held following the reported transaction included 2,952 shares of Class A common stock underlying restricted stock units, which vest on the date of this Form 4. |